On-Demand Recordings

4th Annual Pink & Teal Conference 2021

July 23, 2021
PinkandTeal2021.com

Conference Collaborator

EVENT INFORMATION

This is a recorded CME-Accredited On-Demand Online Activity
Upon registration, confirmation will be provided via email with login instructions

Registration

P&T | Registration

* First Name

* Last Name

* Degree * Degree

* Institution

* Specialty

* Address

* Phone

* Email

* How did you hear about this conference? * How did you hear about this conference?

Please send me information about upcoming events

Please send me information about upcoming events.

reCAPTCHA

If you are human, leave this field blank.

CONFERENCE PLATFORM

The 4th Annual Pink & Teal conference was held live online utilizing a multimedia webcast and virtual conference platform to livestream the keynote, plenary sessions and ancillary events along with moderated Q&A panel discussions. The conference is being offered on-demand until September 17th.

Goal Statement

The purpose of this conference is to educate practitioners and update their knowledge of the biologic pathways associated with Breast & Ovarian Cancers. The conference will also discuss the existing and emerging therapies for the management of patients with these cancers.

TARGET AUDIENCE

Medical, surgical, and radiation oncologists as well as primary care physicians, gynecologists, medical professionals and health care professionals with an interest in breast and ovarian cancer are invited to attend.

LEARNING OBJECTIVES

After completing this activity, participants will be able to:

Describe the evolving gene mutational spectrum of malignant breast and ovarian cancers as well as the genetic implications of these diseases.

List the advances in biologic knowledge and treatments, including hormonal, chemotherapeutic, and targeted based treatments for breast and ovarian cancers.

Discuss the shift in knowledge and treatment decision making in breast and ovarian cancers.

Explain the current knowledge on hematologic complications of COVID-19 and the impact of vaccines on the treatment, efficacy, and health of patients being treated for these malignancies.

AGENDA

DOWNLOAD AGENDA

Course Chairs

Francis Arena, MD
Director,
NYU Langone Arena Oncology
Clinical Professor,
NYU Health Medical College
President and Director of Research,
Sass Foundation for Medical Research
Lake Success, NY

Maria Theodoulou, MD
Program Director
Breast Cancer Medicine
New York Oncology Hematology
Albany, New York

FACULTY

William Audeh M.D., M.S.
Chief Medical Officer
Agendia Inc.
Irvine, CA
Member, Medical Staff
Cedars-Sinai Medical Center
Los Angeles, CA

Leslie R. Boyd, MD
Director, Division of Gynecologic Oncology
Fellowship Director
Associate Professor of Obstetrics and Gynecology
Perlmutter Cancer Center
An NCI-designated Comprehensive Cancer Center
NYU Langone Health
New York, NY

Chau T. Dang, MD
Medical Director, MSK Westchester
Breast Medicine Service
Professor of Medicine
Memorial Sloan Kettering Cancer Center
New York, NY

Judy E. Garber, MD, MPH
Professor, Medicine
Harvard Medical School
Susan F. Smith Chair
Chief, Division of Cancer Genetics and Prevention
Dana-Farber Cancer Institute
Boston, MA

Sudhir Gupta, MD, Ph.D., D.Sc. (h.c.), MACP, FRCP (C), FRCP (Lond)
Professor of Medicine, Pathology & Laboratory
Medicine, and Microbiology & Molecular Genetics
Chief, Basic and Clinical Immunology
Member, Cancer Research Institute
University of California at Irvine
Irvine, CA

Claudine Isaacs, MD
Professor of Medicine
Associate Director, Clinical Research
Georgetown University
Washington, DC

Franco Muggia, MD
Professor of Medicine (Oncology)
Perlmutter Cancer Center
NYU Grossman School of Medicine
New York, NY

Mark E. Robson, MD
Chief, Breast Medicine Service
Attending Physician, Breast Medicine and
Clinical Genetics Services
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
New York, NY

Tiffany A. Traina, MD
Vice Chair, Oncology Care,
Department of Medicine
Associate Attending Physician
Section Head, Triple Negative Breast Cancer
Clinical Research Program
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine, Weill Cornell Medicine
New York, NY

Maria Theodoulou, MD (Course Director)

Medical Oncologist

New York Oncology Hematology

Albany, NY

Francis Arena, MD
Director, NYU Langone Arena Oncology
Clinical Professor, NYU Health Medical College
Lake Success, NY

Jeanne Carter, PhD
Head, Female Sexual Medicine and Women's Health Program
Memorial Sloan Kettering Cancer Center
New York, NY

Todd Doyle, MD
Director of Radiation Therapy
New York Oncology Hematology
Albany, NY

ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and myMedEd, Inc. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.

ASSURANCE OF BALANCED, UNBIASED, AND FAIR CONTENT

It is the policy of The University of Chicago Pritzker School of Medicine to ensure balance, independence, objectivity, and scientific rigor in all its individually provided or jointly provided educational activities. Individuals who are in a position to control the content of any educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Mechanisms to ensure that presentations are free from commercial bias are in place. Faculty will also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.

Accredited Provider

This Activity is Planned by myMedEd, Inc.